NANNOCEL
LIVE

Serial Number

79457617

Owner

Algiecel A/S

Filing Date

Jul 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NANNOCEL Trademark

Serial Number: 79457617

NANNOCEL is a trademark filed by Algiecel A/S on July 2, 2026. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 31 (Natural Agricultural Products). The application is currently pending registration.

Owner Contact Info

Algiecel A/S

Hunderupvej 89

Entity Type: 98

Trademark Details

Filing Date

July 2, 2026

Registration Date

Not Registered

Goods & Services

Processed herbs.

Dietary supplements and dietary preparations; dietary and nutritional supplements; dietary and nutritional supplements for humans and animals; dietary foods for infants; dietary foods adapted for medical use for young children; dietary and nutritional supplements; dietary supplement in powder form; dietary supplements; dietary supplements in liquid form; dietary supplements in the form of drinks; food supplements, not for medical purposes; dietary supplements for animal feed, for medical purposes; dietary supplements with cosmetic effect; nutraceuticals for humans; protein for use as a dietary supplement.

Chemical compositions and materials for the manufacture of cosmetic preparations; botanical extracts for the manufacture of cosmetics; chemical products for the manufacture of cosmetics; plant extracts for use in the manufacture of cosmetics.

Foodstuffs, feedstuff and fodder for animals; beverages for dogs; beverages for cats; beverages for animals; beverages for pets; animal feed of vegetable origin; fodder for animals and pet feed; dog food; pet food; cat food; concentrated feed for animals; dairy animal feed; edible treats for animals.

Animal care products.

Dairy products and dairy substitutes; edible oils and fats.

Healthcare of people.

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2026 REPR